← SynDRA
CCT129202
SynDRA canonical compound SYN1970390 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | AURKA | AURKB | AURKC |
| Mechanism of action | Aurora kinase inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- CCT 129202
- 2-(4-(6-chloro-2-(4-(dimethylamino)phenyl)-1H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide
- CHEMBL392525
- 8N349V9Q27
- 2-(4-(6-chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide
- 1-Piperazineacetamide, 4-(6-chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo(4,5-b)pyridin-7-yl)-N-2-thiazolyl-
- 2-(4-(6-Chloro-2-(4-dimethylaminophenyl)-3H-imidazo(4,5-b)pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide
- 2-[4-[6-chloro-2-[4-(dimethylamino)phenyl]-1H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]-N-(1,3-thiazol-2-yl)acetamide
- 1-piperazineacetamide, 4-[6-chloro-2-[4-(dimethylamino)phenyl]-3H-imidazo[4,5-b]pyridin-7-yl]-N-2-thiazolyl-
- UNII-8N349V9Q27
- MLS006011038
- SCHEMBL209571
- DTXSID50241406
- BCPP000297
- HMS3654B20
- BCP02164
- BDBM50224734
- s1519
- ZINC28824607
- AKOS030230261
- BCP9000497
- CCG-269670
- CS-0206
- SB19307
- NCGC00346539-01
- NCGC00346539-05
- HY-12049
- SMR004702831
- SW219480-1
- A25040
- J-505098
- Q27270773
- 2-(4-(6-Chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo[4,5-b]-pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide
- 2-(4-(6-chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-4-yl)acetamide
- 2-{4-[6-Chloro-2-(4-dimethylamino-phenyl)-3H-imidazo[4,5-b]pyridin-7-yl]-piperazin-1-yl}-N-thiazol-2-yl-acetamide
Look up CCT129202 in the interactive SynDRA portal →